0001841262-21-000001.txt : 20210120
0001841262-21-000001.hdr.sgml : 20210120
20210120130812
ACCESSION NUMBER: 0001841262-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210120
DATE AS OF CHANGE: 20210120
EFFECTIVENESS DATE: 20210120
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RITROVA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001841262
IRS NUMBER: 850990409
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-386817
FILM NUMBER: 21538065
BUSINESS ADDRESS:
STREET 1: 37 WASHINGTON SQUARE WEST
STREET 2: APT 16D
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 929-284-5678
MAIL ADDRESS:
STREET 1: 37 WASHINGTON SQUARE WEST
STREET 2: APT 16D
CITY: NEW YORK
STATE: NY
ZIP: 10011
D
1
primary_doc.xml
X0708
D
LIVE
0001841262
RITROVA THERAPEUTICS INC.
37 WASHINGTON SQUARE WEST
APT 16D
NEW YORK
NY
NEW YORK
10011
929-284-5678
DELAWARE
Ritrova Therapeutics LLC
None
Corporation
true
2021
Cristina Maria
Alberini
37 Washington Square West
Apt 16D
New York
NY
NEW YORK
10011
Executive Officer
Director
Other
Decline to Disclose
- 06b
false
2021-01-11
false
true
false
0
3000000
150000
2850000
false
2
0
0
0
false
RITROVA THERAPEUTICS INC.
/s/ Cristina Maria Alberini
Cristina Maria Alberini
Chief Executive Officer
2021-01-20